Author/Editor | Samsa, Žiga; Štupar, Saša | |
Title | Antiagregacijska terapija v medoperativnem in pooperativnam obdobju | |
Translated title | Antiplatelets use in peri- and post-operative period | |
Type | članek | |
Source | In: Zbornik predavanj XLIX. podiplomskega tečaja kirurgije za zdravnike, [Portorož], 15. in 16. november 2019 Ljubljana : Slovensko zdravniško društvo | |
Publication year | 2019 | |
Volume | str. Str.: 282-288 | |
Language | slv | |
Abstract | Število bolnikov, ki prejemajo antiagregacijsko terapijo stalno narašča, s tem narašča tudi tveganje za zaplete v medoperativnem in pooperativnem obdobju. Jasnih usmeritev za obravnavo nevrokirurških bolnikov na tem področju zaenkrat ni. Kot antiagregacijska terapija se pri nas najpogosteje uporablja monoterapija z acetilsalicilno kislino ter kombinirana terapija z acetilsalicilno kislino in zaviralci P2Y 12 receptorjev. Ukinitev, prekinitev in ponovna uvedba terapije je odvisna od osnovne indikacije za uvedbo ter vrste posega.The number of patients receiving antiplatelet therapy is steadily increasing, thus the risk of complications during the operative and postoperative period also rizes. There are currently no clear guidelines for treating neurosurgical patients in this area. Most commonly used antiaggregation therapy is acetylsalicylic acid and P2Y 12 receptor inhibitors. Discontinuation, interruption and reinitiation of therapy depend on the primary indication and the type of intervention. | |
Descriptors | Platelet Aggregation Inhibitors Neurosurgery Inhibitorji trombocitne agregacije Nevrokirurgija |